Synapse - Works

Results (2478)

PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes

Meeting Abstract

Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
Blood (2018)

Fulltext@MSK | Save

Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia

Meeting Abstract

Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
Blood (2018)

Fulltext@MSK | Save

Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy

Meeting Abstract

Talati, C.; Goldberg, A. D.; Przespolewski, A.; Chan, O.; Al Ali, N.; Famulare, C.; Sallman, D. A.; Padron, E.; Kuykendall, A.; List, A. F.; more...
Blood (2018)

Fulltext@MSK | Save

Genomic landscape impacts induction outcome with CPX-351 in patients with acute myeloid leukemia

Meeting Abstract

Talati, C.; Goldberg, A. D.; Desai, P.; Chan, O.; Famulare, C.; Komrokji, R. S.; Kuykendall, A. T.; Fernandez, H. F.; Deutsch, Y. E.; Padron, E.; more...
Blood (2018)

Fulltext@MSK | Save

Resource utilization early after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies

Meeting Abstract

Shah, G. L.; Park, J. H.; Sauter, C. S.; Duck, E.; Halton, E.; Palomba, M. L.; Batlevi, C. L.; Younes, A.; Geyer, M. B.; Smith, E. L.; more...
Blood (2018)

Fulltext@MSK | Save

Double-unit cord blood (CB) transplantation with haplo-identical CD34+ cells (haplo-dCBT) may speed neutrophil recovery although successful bridging is contingent on close haplo-winning CB unit HLA-match

Meeting Abstract

Politikos, I.; Devlin, S. M.; Mazis, C.; Maloy, M.; Naputo, K.; Afuye, A. O.; Bhatt, V.; Scaradavou, A.; O'Reilly, R. J.; Avecilla, S. T.; more...
Blood (2018)

Fulltext@MSK | Save

Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial

Meeting Abstract

Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
Blood (2018)

Fulltext@MSK | Save

Blinatumomab administered concurrently with oral tyrosine kinase inhibitor therapy is a well-tolerated consolidation strategy and eradicates measurable residual disease in adults with Philadelphia chromosome positive acute lymphoblastic leukemia

Meeting Abstract

King, A. C.; Pappacena, J.; Tallman, M. S.; Park, J. H.; Geyer, M. B.
Blood (2018)

Fulltext@MSK | Save

TP53 mutations predict poorer responses to CPX-351 in acute myeloid leukemia

Meeting Abstract

Goldberg, A. D.; Talati, C.; Desai, P.; Famulare, C.; Devlin, S. M.; Farnoud, N.; Sallman, D. A.; Lancet, J. E.; Roboz, G. J.; Sweet, K. L.; more...
Blood (2018)

Fulltext@MSK | Save

Addition of crenolanib to induction chemotherapy overcomes the poor prognostic impact of co-occurring driver mutations in patients with newly diagnosed FLT3-mutated AML

Meeting Abstract

Goldberg, A. D.; Collins, R. H.; Stone, R. M.; Walter, R. B.; Karanes, C.; Vigil, C. E.; Wang, E. S.; Tallman, M. S.
Blood (2018)

Fulltext@MSK | Save